Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
ConclusionGiven the concern for MDR P. aeruginosa infections in CF patients, BT may offer a viable anti-infective adjunct to traditional antibiotic therapy.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Antibiotic Therapy | Cystic Fibrosis | Infectious Diseases | Lung Transplant | Multidrug Resistance | Pneumonia | Renal Failure | Respiratory Medicine | Transplants